Biogen Wins Approval with FDA for Alzheimer’s Drug

This morning Biogen (NASDAQ:BIIB) received approval from the FDA for their Alzheimer’s drug aducanumab. The FDA decision marks the first new Alzheimer’s disease drug since 2003 to receive approval and the first that aims to slow disease progression.

The drug aims to remove sticky deposits of a protein called amyloid-beta from the brains of patients in earlier stages of Alzheimer’s. The goal of the drug is to stave off its ravages, which include memory loss and the ability to care for one’s self.

The FDA decision was originally supposed to land in March, but was extended in January for additional review. The early data on the drug showed mixed results with some doctors saying clinical trial results were inconsistent and further confirmation was needed.

Before this decision landed, J.P. Morgan analyst Cory Kasimov called the FDA’s decision “the mother of all binary events.”

The stock is currently halted and last traded at $286.43


Information for this briefing was found via the FDA, Biogen, JP Morgan, and Reuters. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

Biogen Trades At 12-Month High Following Alzheimer’s Drug Success, US$900-Million Settlement On Kickback Lawsuit

Fresh off a US$900 million settlement agreement, Biogen, Inc (Nasdaq: BIIB) announced positive topline results...

Wednesday, September 28, 2022, 03:04:00 PM

FDA Declares Lab-Grown Chicken Safe for Human Consumption

The US Food and Drug Administration (FDA) has approved lab-grown meat for human consumption, marking...

Thursday, November 17, 2022, 04:49:26 PM

Mass Layoffs Hit FDA, CDC and Other Health Agencies

The Trump administration has initiated sweeping layoffs at key US health agencies, with approximately 10,000...

Wednesday, April 2, 2025, 02:19:00 PM

Tobacco (Finally) Falls Out of Favor As Legal Marijuana Continues to Gain Public Support

American society is witnessing a remarkable shift in attitudes toward cannabis and tobacco. Once upon...

Monday, March 13, 2023, 08:09:52 AM

Biogen Pays $900 Million To Settle Kickback Lawsuit

Biogen, Inc (NASDAQ: BIIB) has reached a US$900 million deal to resolve a long-running whistleblower...

Friday, July 22, 2022, 09:38:00 AM